Praxisorientierte Darstellung der deutschen S3-Leitlinie „Strategien zur Sicherung rationaler Antibiotika-Anwendungen im Krankenhaus“

Die aktuelle S3-Leitlinie „Strategien zur Sicherung rationaler Antibiotika-Anwendung im Krankenhaus“ [1] fasst evidenzbasierte Maßnahmen der Antibiotic Stewardship (ABS) zusammen, die zur Sicherung einer guten Patientenversorgung und zur Bekämpfung der mikrobiellen Resistenzentwicklung in deutschen Kliniken beitragen sollen. Der Beitrag stellt die Leitlinie vor.

Abstract

The current S3 guideline entitled “Strategies to warrant rational in-hospital use of antibiotics” summarizes evidence-based antibiotic stewardship (ABS) measures that aim to improve clinical outcomes and prevent development and spread of microbial resistance in German hospitals. Most important prerequisite for efficiency and safety of ABS programs is sufficient staffing capacity as well as reliably operating surveillance of (i) pathogens, (ii) antimicrobial resistance and (iii) consumption of antimicrobials. ABS teams require authorization by hospital institutions as units exclusively responsible for antimicrobial audits and implementation of anti-infective interventions. Clinicians should be regularly granted access to in-hospital training programs delivered by ABS experts. Finally yet importantly, the current S3 guideline also highlights future goals, e.g., the structured involvement for nurses in ABS-guided infection management or the promotion of ABS programs in the outpatient sector and in veterinary medicine.

Schlüsselwörter

Rationale Antibiotikaanwendung - ABS - mikrobielle Resistenz - Antibiotika - Krankenhaus

Keywords

antibiotic stewardship - microbial resistance - antibiotics - hospital

• Literatur

• 1 De With K, Wilke K, Kern V. et al. S3-Leitlinie: Strategien zur Sicherung rationaler Antibiotika-Anwendung im Krankenhaus. AWMF-Registernummer 092/001 2019; update 2018. Accessed February 28, 2022 at: https://www.awmf.org/leitlinien/detail/ll/092–001.html
• 2 World Health Organization – WHO. Global Action Plan on antimicrobial Resistance. Geneva: World Health Organization; 2015
• 3 https://ec.europa.eu/health/system/files/2020-01/amr_2017_action-plan_0.pdf
• 4 Monette J, Miller MA, Monette M. et al. Effect of an educational intervention on optimizing antibiotic prescribing in long-term care facilities. J Am Geriatr Soc 2007; 55: 1231-1235
• 5 Guo Y, Gao W, Yang H. et al. De-escalation of empiric antibiotics in patients with severe sepsis or septic shock: A meta-analysis. Heart Lung 2016; 45: 454-459
• 6 Silva BN, Andriolo RB, Atallah AN. et al. De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock. Cochrane Database Syst Rev 2013; (03) CD007934
• 7 Gomes Silva BN, Andriolo RB, Atallah AN. et al. De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock. Cochrane Database Syst Rev 2010; (12) CD007934
• 8 Forst G, de With K, Weber N. et al. Validation of adapted daily dose definitions for hospital antibacterial drug use evaluation: a multicentre study. J Antimicrob Chemother 2017; 72: 2931-2937
• 9 Kern WV, Fellhauer M, Hug M. et al. Antibiotika-Anwendung 2012/13 in 109 deutschen Akutkrankenhäusern. Dtsch Med Wochenschr 2015; 140: e237-e246
• 10 Albrich WC, Monnet DL, Harbarth S. Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg Infect Dis 2004; 10: 514-517
• 11 Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin – DGP. S3-Leitlinie Behandlung von erwachsenen Patienten mit ambulant erworbener Pneumonie und Prävention. Accessed February 28, 2022 at: https://www.awmf.org/leitlinien/detail/ll/020–020.html
• 12 Deutsche Gesellschaft für Urologie – DGU (federführend). Interdisziplinäre S3-Leitlinie: Epidemiologie, Diagnostik, Therapie, Prävention und Management unkomplizierter, bakterieller, ambulant erworbener Harnwegsinfektionen bei erwachsenen Patienten. AWMF Registernummer: 043/044. 2017 Accessed February 28, 2022 at: https://www.awmf.org/uploads/tx_szleitlinien/043–044l_S3_Harnwegsinfektionen_2017–05.pdf
• 13 Pugh R, Grant C, Cooke RPD. et al. Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults. Cochrane Database Syst Rev 2015; (08) CD007577
• 14 Uranga A, Espana PP, Bilbao A. et al. Duration of antibiotic treatment in community-acquired pneumonia: a multicenter randomized clinical trial. JAMA Intern Med 2016; 176: 1257-1265
• 15 Dinh A, Davido B, Bouchand F. et al. Honey, I shrunk the antibiotic therapy. Clin Infect Dis 2018; 66: 1981-1982
• 16 Sawyer RG, Claridge JA, Nathens AB. et al. Trial of short-course antimicrobial therapy for intraabdominal infection. N Engl J Med 2015; 372: 1996-2005
• 17 Sandberg T, Skoog G, Hermansson AB. et al. Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial. Lancet 2012; 380: 484-490
• 18 Schuetz P, Wirz Y, Sager R. et al. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis 2018; 18: 95-107
• 19 Athanassa Z, Makris G, Dimopoulos G. et al. Early switch to oral treatment in patients with moderate to severe community-acquired pneumonia: a meta-analysis. Drugs 2008; 68: 2469-2481
• 20 Smyth AR, Bhatt J, Nevitt SJ. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis. Cochrane Database Syst Rev 2017; (03) CD002009
• 21 Vardakas KZ, Voulgaris GL, Maliaros A. et al. Prolonged versus short-term intravenous infusion of antipseudomonal beta-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials. Lancet Infect Dis 2018; 18: 108-120
• 22 Zimmermann SH. MiQ: Qualitätsstandards in der mikrobiologisch-infektiologischen Diagnostik. Loseblatt. München: Urban & Fischer/Elsevier; 2020
• 23 Kochanek M, Michels G, Seifert H. Mikrobiologische Infektionsdiagnostik auf der Intensivstation. Intensivmedizin up2date 2014; 10: 233-248
• 24 Kochanek M, Böll B, Shimabukuro-Vornhagen A. et al. Personalbedarf einer Intensivstation unter Berücksichtigung geltender Hygienerichtlinien. Dtsch Med Wochenschr 2015; 140: e136-e141